We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





Clinical Chemistry Instruments and Reagents Under Scrutiny at the 2015 AACC Annual Meeting

By LabMedica International staff writers
Posted on 27 Jul 2015
Clinical chemistry, both instrumentation and reagents, was the focus of presentations at booth 1018 at the 2015 AACC Annual Meeting & Clinical Lab Expo (Atlanta, GA, USA).

EKF Diagnostics (Cardiff, United Kingdom), a global in vitro diagnostics company, took advantage of the AACC Annual Meeting to launch the Altair 240 clinical chemistry analyzer.

This new bench-top platform represents EKF Diagnostics’ first fully integrated chemistry system designed for the global market. More...
EKF believes that the new Altair 240 clinical chemistry analyzer fulfills an international market need for a fully automated bench-top platform supported by the reliable Stanbio Chemistry (Boerne, TX, USA) reagent menu.

“We listened to the needs of our customers and designed the Altair 240 to be easy to learn, operate, and maintain,” said Albert Blanco, business unit director at EKF Diagnostics. “Because it runs on Windows 7, operators can easily navigate its intuitive, touch screen menu. Features such as the capability to use bar coded, primary sample tubes, auto-rerun, auto-dilution and STAT interruption—all function to maximize the system’s overall efficiency.”

EKF will also use the AACC Annual Meeting venue to discuss the latest additions to its Stanbio clinical chemistry range. This range includes a large selection of clinical chemistry assays, controls, and calibrators, which are fully compatible with most major brand open channel chemistry analyzers.

A notable addition to the reagent menu is the Stanbio Chemistry Glycated Serum Protein (GSP) LiquiColor test; a new diabetes biomarker test that provides a two to three week indicator of average blood glucose. The GSP LiquiColor test is based on a double enzymatic degradation method that utilizes the specificity of fructosyl-amino oxidase to eliminate inaccuracies caused by non-glycated protein reducing substances, which significantly interfere with the NBT fructosamine method. The test is available as a liquid-stable kit with calibrator. It is suitable for use on a variety of clinical chemistry analyzers, with on-board stability of up to four weeks.

Other instruments to be highlighted at the AACC Annual Meeting include the DiaSpect and HemoPoint H2. DiaSpect is a hand held device touted as being the world’s fastest hemoglobin measurement system. The instrument is described as offering laboratory quality performance for anemia screening in all climatic conditions in less than two seconds. The HemoPoint H2 stores over 4000 patient results and is designed for use in blood banks, clinics, and hospitals. This instrument provides immediate and simultaneous high quality results for both hemoglobin and hematocrit.

Related Links:

2015 AACC Annual Meeting & Clinical Lab Expo
EKF Diagnostics
Stanbio Chemistry



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Monarch Mag Cell-free DNA (cfDNA) Extraction Kit provides isolation of low-abundance cfDNA from a range of biofluids (Photo courtesy of New England Biolabs)

New Extraction Kit Enables Consistent, Scalable cfDNA Isolation from Multiple Biofluids

Circulating cell-free DNA (cfDNA) found in plasma, serum, urine, and cerebrospinal fluid is typically present at low concentrations and is often highly fragmented, making efficient recovery challenging... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.